DOCSLIB.ORG

Dextromethorphan Product List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dextromethorphan Product List Dextromethorphan Product List Information to create this list was taken from the Federal Food and Drug Administrations's National Drug Code Directory. If reviewing the list on the FDA’s page, please use the search criteria Nonproprietary Name, and Dextromethorphan. A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Labeler Name Proprietary Name Package Description Strength Non-Proprietary Name Product NDC 7-Eleven 7 select night time relief 8 BLISTER PACK in 1 CARTON 325 mg/1, 15 mg/1, 6.25 Acetaminophen, 10202-056 (10202-056-73) > 2 CAPSULE, mg/1 Dextromethorphan HBr, GELATIN COATED in 1 BLISTER PACK Doxylamine succinate 7-Eleven 7 select night time relief 354 mL in 1 BOTTLE (10202-335-40) 650 mg/30mL, 30 Acetaminophen, 10202-335 mg/30mL, 12.5 mg/30mL Dextromethorphan HBr, Doxylamine succinate 7-Eleven 7 select day time relief 354 mL in 1 BOTTLE (10202-656-40) 325 mg/15mL, 10 acetaminophen, 10202-656 mg/15mL, 5 mg/15mL dextromethorphan Hbr, Phenylephrine HCl 7-Eleven 7 select day time relief 8 BLISTER PACK in 1 CARTON 325 mg/1, 10 mg/1, 5 mg/1 Acetaminophen, 10202-994 (10202-994-73) > 2 CAPSULE, Dextromethorphan HBr, LIQUID FILLED in 1 BLISTER PACK Phenylephrine HCl 7-Eleven 7 Select Cough DM 1 BOTTLE in 1 CARTON (10202-384- 30 mg/5mL dextromethorphan polistirex 10202-384 21) > 89 mL in 1 BOTTLE A A&Z Holistic Products, Inc. Daytime Cold and Flu Relief 1 BLISTER PACK in 1 BOX (69619- 325 mg/1, 10 mg/1, 5 mg/1 Acetaminophen, 69619-303 303-10) > 10 CAPSULE, LIQUID Dextromethorphan HBr, FILLED in 1 BLISTER PACK Phenylephrine HCI Labeler Name Proprietary Name Package Description Strength Non-Proprietary Name Product NDC AAA Pharmaceutical, Inc. Acetaminophen, Chlorpheniramine Maleate, 2 BLISTER PACK in 1 CARTON 325 mg/1, 2 mg/1, 10 ACETAMINOPHEN, 57344-139 Dextromethorphan Hydrobromide, Phenylephrine (57344-139-02) > 12 TABLET, mg/1, 5 mg/1 CHLORPHENIRAMINE Hydrochloride COATED in 1 BLISTER PACK MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE AAA Pharmaceutical, Inc. Acetaminophen, Chlorpheniramine Maleate, 2 BLISTER PACK in 1 CARTON 325 mg/1, 2 mg/1, 10 ACETAMINOPHEN, 57344-161 Dextromethorphan Hydrobromide, Phenylephrine (57344-161-02) > 12 TABLET, mg/1, 5 mg/1 CHLORPHENIRAMINE Hydrochloride COATED in 1 BLISTER PACK MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE AAA Pharmaceutical, Inc. Acetaminophen, Dextromethorphan Hydrobromide, 1 BLISTER PACK in 1 CARTON 325 mg/1, 10 mg/1, 100 ACETAMINOPHEN, 57344-134 Guaifenesin, Phenylephrine Hydrochloride (57344-134-02) > 10 TABLET, mg/1, 5 mg/1 DEXTROMETHORPHAN COATED in 1 BLISTER PACK HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE AAA Pharmaceutical, Inc. Acetaminophen, Dextromethorphan Hydrobromide, 2 BLISTER PACK in 1 CARTON 325 mg/1, 10 mg/1, 100 ACETAMINOPHEN, 57344-134 Guaifenesin, Phenylephrine Hydrochloride (57344-134-03) > 10 TABLET, mg/1, 5 mg/1 DEXTROMETHORPHAN COATED in 1 BLISTER PACK HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE DOH 690-292 May 2016 2 of 379 Labeler Name Proprietary Name Package Description Strength Non-Proprietary Name Product NDC AAA Pharmaceutical, Inc. Acetaminophen, Dextromethorphan Hydrobromide, 2 BLISTER PACK in 1 CARTON 325 mg/1, 10 mg/1, 200 ACETAMINOPHEN, 57344-136 Guaifenesin, Phenylephrine Hydrochloride (57344-136-02) > 12 TABLET, mg/1, 5 mg/1 DEXTROMETHORPHAN COATED in 1 BLISTER PACK HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE AAA Pharmaceutical, Inc. Acetaminophen, Dextromethorphan Hydrobromide, 2 BLISTER PACK in 1 CARTON 325 mg/1, 10 mg/1, 200 ACETAMINOPHEN, 57344-163 Guaifenesin, Phenylephrine Hydrochloride (57344-163-02) > 12 TABLET, mg/1, 5 mg/1 DEXTROMETHORPHAN COATED in 1 BLISTER PACK HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE AAA Pharmaceutical, Inc. Acetaminophen, Dextromethorphan Hydrobromide, 2 BLISTER PACK in 1 CARTON 325 mg/1, 10 mg/1, 200 ACETAMINOPHEN, 57344-163 Guaifenesin, Phenylephrine Hydrochloride (57344-163-05) > 12 TABLET, mg/1, 5 mg/1 DEXTROMETHORPHAN COATED in 1 BLISTER PACK HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE AAA Pharmaceutical, Inc. Acetaminophen, Dextromethorphan Hydrobromide, 2 BLISTER PACK in 1 CARTON 325 mg/1, 10 mg/1, 200 Acetaminophen, 57344-159 Guaifenesin, Phenylephrine Hydrochloride (57344-159-02) > 12 TABLET, mg/1, 5 mg/1 Dextromethorphan COATED in 1 BLISTER PACK Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride AAA Pharmaceutical, Inc. Acetaminophen, Dextromethorphan Hydrobromide, 2 BLISTER PACK in 1 CARTON 325 mg/1, 10 mg/1, 5 mg/1 ACETAMINOPHEN, 57344-160 Phenylephrine Hydrochloride (57344-160-02) > 12 TABLET, DEXTROMETHORPHAN COATED in 1 BLISTER PACK HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE DOH 690-292 May 2016 3 of 379 Labeler Name Proprietary Name Package Description Strength Non-Proprietary Name Product NDC AAA Pharmaceutical, Inc. Acetaminophen, Dextromethorphan Hydrobromide, 2 BLISTER PACK in 1 CARTON 325 mg/1, 10 mg/1, 5 mg/1 ACETAMINOPHEN, 57344-138 Phenylephrine Hydrochloride (57344-138-02) > 12 TABLET, DEXTROMETHORPHAN COATED in 1 BLISTER PACK HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE AAA Pharmaceutical, Inc. Acetaminophen, Dextromethorphan Hydrobromide, 2 BLISTER PACK in 1 CARTON 325 mg/1, 10 mg/1, 5 mg/1 ACETAMINOPHEN, 57344-138 Phenylephrine Hydrochloride (57344-138-05) > 12 TABLET, DEXTROMETHORPHAN COATED in 1 BLISTER PACK HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE AAFES/Your Military Exchanges Nite Time Cold and Flu 355 mL in 1 BOTTLE, PLASTIC 650 mg/30mL, 30 Acetaminophen, 55301-344 (55301-344-12) mg/30mL, 12.5 mg/30mL Dextromethorphan Hydrobromide, Doxylamine Succinate AAFES/Your Military Exchanges Cold and Flu Relief 355 mL in 1 BOTTLE, PLASTIC 650 mg/30mL, 30 Acetaminophen, 55301-043 (55301-043-12) mg/30mL, 12.5 mg/30mL Dextromethorphan Hydrobromide, Doxylamine Succinate AAFES/Your Military Exchanges Mucus Relief 177 mL in 1 BOTTLE, PLASTIC 650 mg/20mL, 20 Acetaminophen, 55301-336 (55301-336-06) mg/20mL, 400 mg/20mL, Dextromethorphan HBr, 10 mg/20mL Guaifenesin, Phenylephrine HCl AAFES/Your Military Exchanges Daytime Cold and Flu 355 mL in 1 BOTTLE, PLASTIC 325 mg/15mL, 10 Acetaminophen, 55301-066 (55301-066-12) mg/15mL, 5 mg/15mL Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride DOH 690-292 May 2016 4 of 379 Labeler Name Proprietary Name Package Description Strength Non-Proprietary Name Product NDC AAFES/Your Military Exchanges Severe cold and cough relief 245 mL in 1 BOTTLE, PLASTIC 650 mg/30mL, 20 Acetaminophen, 55301-316 (55301-316-08) mg/30mL, 10 mg/30mL Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride AAFES/Your Military Exchanges Tussin Cough and Chest Congestion DM 1 BOTTLE, PLASTIC in 1 BOX (55301- 10 mg/5mL, 100 mg/5mL Dextromethorphan HBr, 55301-384 384-04) > 118 mL in 1 BOTTLE, Guaifenesin PLASTIC AAFES/Your Military Exchanges Tussin Cough and Chest Congestion DM 1 BOTTLE, PLASTIC in 1 BOX (55301- 20 mg/10mL, 200 mg/10mL Dextromethorphan HBr, 55301-385 385-08) > 237 mL in 1 BOTTLE, Guaifenesin PLASTIC AAFES/Your Military Exchanges Mucus Relief Severe Congestion and Cough 177 mL in 1 BOTTLE, PLASTIC 20 mg/20mL, 400 Dextromethorphan HBr, 55301-337 (55301-337-06) mg/20mL, 10 mg/20mL Guaifenesin, Phenylephrine HCl AAFES/Your Military Exchanges Tussin Multi Symptom Cold CF 1 BOTTLE, PLASTIC in 1 BOX (55301- 20 mg/10mL, 200 Dextromethorphan HBr, 55301-382 382-08) > 237 mL in 1 BOTTLE, mg/10mL, 10 mg/10mL Guaifenesin, Phenylephrine PLASTIC Aaron Industries Inc Tussin Cough Long Acting 118 mL in 1 BOTTLE, PLASTIC 10 mg/5mL Robitussin Cough Long Acting 49580-3412 (49580-3412-4) Aaron Industries Inc Tussin CF 118 mL in 1 BOTTLE, PLASTIC 10 mg/5mL, 100 mg/5mL, 5 Robitussin CF 49580-0126 (49580-0126-4) mg/5mL Aaron Industries Inc. Night time cold and flu 355 mL in 1 BOTTLE, PLASTIC 500 mg/15mL, 15 Acetaminophen, 49580-0342 (49580-0342-2) mg/15mL, 6.25 mg/15mL Dextromethorphan Hydrobromide, Doxylamine Succinate Aaron Industries Inc. Nighttime Cold and Flu 177 mL in 1 BOTTLE, PLASTIC 500 mg/15mL, 15 Acetaminophen, 49580-0344 (49580-0344-6) mg/15mL, 6.25 mg/15mL Dextromethorphan Hydrobromide, Doxylamine Succinate DOH 690-292 May 2016 5 of 379 Labeler Name Proprietary Name Package Description Strength Non-Proprietary Name Product NDC Aaron Industries Inc. Day Time Cold and Flu 296 mL in 1 BOTTLE, PLASTIC 325 mg/15mL, 10 Acetaminophen, 49580-0311 (49580-0311-1) mg/15mL, 5 mg/15mL Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride Aaron Industries Inc. Nighttime Cough 296 mL in 1 BOTTLE (49580-0345-1) 30 mg/30mL, 12.5 Dextromethorphan 49580-0345 mg/30mL Hydrobromide, Doxylamine Succinate Aaron Industries Inc. Tussin DM Cough and Chest Congestion 1 BOTTLE, PLASTIC in 1 BOX (49580- 10 mg/5mL, 100 mg/5mL Dextromethorphan HBr, 49580-0384 0384-4) > 118 mL in 1 BOTTLE, Guaifenesin PLASTIC Aaron Industries Inc. Tussin DM Cough and Chest Congestion 1 BOTTLE, PLASTIC in 1 BOX (49580- 20 mg/10mL, 200 mg/10mL Dextromethorphan HBr, 49580-0385 0385-4) > 118 mL in 1 BOTTLE, Guaifenesin PLASTIC Aaron Industries, Inc. Childrens Plus Multi-Symptom Cold Grape 118 mL in 1 BOTTLE, PLASTIC 160 mg/5mL, 1 mg/5mL, 5 Childrens Tylenol Plus Multi- 49580-1434 (49580-1434-4) mg/5mL, 2.5 mg/5mL Symptom Cold Aaron Industries, Inc. Night Time Cherry 177 mL in 1 BOTTLE, PLASTIC 500 mg/15mL, 15 NyQuil Cherry 49580-1403 (49580-1403-4) mg/15mL, 6.25 mg/15mL Aaron Industries, Inc. Night Time Original 177 mL in 1 BOTTLE, PLASTIC 500 mg/15mL, 15 Acetaminophen, 49580-1406 (49580-1406-6) mg/15mL, 6.25 mg/15mL Dextromethorphan Hydrobromide, Doxylamine Succinate Aaron Industries, Inc. Day Time 296 mL in 1 BOTTLE, PLASTIC 325 mg/15mL, 10 DayQuil 49580-3416 (49580-3416-1) mg/15mL, 5 mg/15mL Aaron Industries, Inc. Day Time with PE 296 mL in 1 BOTTLE, PLASTIC 325 mg/15mL, 10 Acetaminophen, 49580-0142 (49580-0142-1) mg/15mL, 5 mg/15mL Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride Aaron Industries, Inc.
Load more

Recommended publications
  • Appendix a Common Abbreviations Used in Medication
    UNIVERSITY OF AMSTERDAM MASTERS THESIS Impact of Medication Grouping on Fall Risk Prediction in Elders: A Retrospective Analysis of MIMIC-III Critical Care Database Student: SRP Mentor: Noman Dormosh Dr. Martijn C. Schut Student No. 11412682 – SRP Tutor: Prof. dr. Ameen Abu-Hanna SRP Address: Amsterdam University Medical Center - Location AMC Department Medical Informatics Meibergdreef 9, 1105 AZ Amsterdam Practice teaching period: November 2018 - June 2019 A thesis submitted in fulfillment of the requirements for the degree of Master of Medical Informatics iii Abstract Background: Falls are the leading cause of injury in elderly patients. Risk factors for falls in- cluding among others history of falls, old age, and female gender. Research studies have also linked certain medications with an increased risk of fall in what is called fall-risk-increasing drugs (FRIDs), such as psychotropics and cardiovascular drugs. However, there is a lack of consistency in the definitions of FRIDs between the studies and many studies did not use any systematic classification for medications. Objective: The aim of this study was to investigate the effect of grouping medications at different levels of granularity of a medication classification system on the performance of fall risk prediction models. Methods: This is a retrospective analysis of the MIMIC-III cohort database. We created seven prediction models including demographic, comorbidity and medication variables. Medica- tions were grouped using the anatomical therapeutic chemical classification system (ATC) starting from the most specific scope of medications and moving up to the more generic groups: one model used individual medications (ATC level 5), four models used medication grouping at levels one, two, three and four of the ATC and one model did not include med- ications.
    [Show full text]
  • Hallucinogens
    Hallucinogens What Are Hallucinogens? Hallucinogens are a diverse group of drugs that alter a person’s awareness of their surroundings as well as their thoughts and feelings. They are commonly split into two categories: classic hallucinogens (such as LSD) and dissociative drugs (such as PCP). Both types of hallucinogens can cause hallucinations, or sensations and images that seem real though they are not. Additionally, dissociative drugs can cause users to feel out of control or disconnected from their body and environment. Some hallucinogens are extracted from plants or mushrooms, and others are synthetic (human-made). Historically, people have used hallucinogens for religious or healing rituals. More recently, people report using these drugs for social or recreational purposes. Hallucinogens are a Types of Hallucinogens diverse group of drugs Classic Hallucinogens that alter perception, LSD (D-lysergic acid diethylamide) is one of the most powerful mind- thoughts, and feelings. altering chemicals. It is a clear or white odorless material made from lysergic acid, which is found in a fungus that grows on rye and other Hallucinogens are split grains. into two categories: Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) comes from certain classic hallucinogens and types of mushrooms found in tropical and subtropical regions of South dissociative drugs. America, Mexico, and the United States. Peyote (mescaline) is a small, spineless cactus with mescaline as its main People use hallucinogens ingredient. Peyote can also be synthetic. in a wide variety of ways DMT (N,N-dimethyltryptamine) is a powerful chemical found naturally in some Amazonian plants. People can also make DMT in a lab.
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • Injectable Anesthesia in South American Camelids
    INJECTABLE ANESTHESIA IN SOUTH AMERICAN CAMELIDS Thomas Riebold DVM, Diplomate ACVAA Veterinary Teaching Hospital College of Veterinary Medicine Oregon State University Corvallis, Oregon 97331 INTRODUCTION Interest in llamas, and more recently in alpacas, as pets and as breeding and pack animals has led to increased demand for veterinary services for them. While they have some unique species characteristics regarding anesthesia, many of the principles and techniques used in food animal and equine anesthesia also apply to South American camelids. Except for differences in size, anesthetic management of alpacas and llamas is similar. Much like there are species differences between cattle, sheep, and goats in their response to xylazine, it does appear that alpacas require higher doses of sedatives, approximately 10-20%, to obtain the same response that lower doses of sedatives would obtain in llamas. PREANESTHETIC CONSIDERATIONS Consideration for preanesthetic preparation includes fasting, assessment of hematologic and blood chemistry values, venous catheterization, and estimation of bodyweight. The camelid has a stomach divided into three compartments. Therefore, potential complications similar to those of domestic ruminants, regurgitation and aspiration pneumonia, exist during anesthesia. Abdominal tympany as it occurs in anesthetized domestic ruminants does not appear to occur in anesthetized camelids. It is recommended that the animals be fasted 12-18 hours and deprived of water for 8-12 hours. In nonelective cases, this is often not possible and precautions should be taken to avoid aspiration of gastric fluid and ingesta. Fasting neonatal camelids is not advisable because hypoglycemia may result. As in other species, hematologic and blood chemistry values are determined before anesthesia.
    [Show full text]
  • “Opioid” Definition Drug Inclusion and Exclusion List
    WSHA WSMA Opioid Prescribing Report Medication Inclusion/Exclusion list For purposes of developing WSHA WSMA Opioid Prescribing Report metrics, the following medications tracked in the Prescription Monitoring Program database were included and counted as “opioid prescriptions”: Drug Name ACETAMINOPHEN-CODEINE ASCOMP WITH CODEINE BELLADONNA-OPIUM BUTALB-ACETAMINOPH-CAFF-CODEIN BUTALB-CAFF-ACETAMINOPH-CODEIN BUTALBITAL COMPOUND-CODEINE BUTORPHANOL TARTRATE CARISOPRODOL-ASPIRIN-CODEINE CHERATUSSIN AC CHERATUSSIN DAC CODEINE SULFATE CODEINE-GUAIFENESIN DEMEROL DILAUDID DOLOPHINE HCL DURAMORPH ENDOCET FENTANYL CITRATE FENTORA FIORICET WITH CODEINE FIORINAL WITH CODEINE #3 GUAIATUSSIN AC GUAIFENESIN AC GUAIFENESIN DAC GUAIFENESIN W/CODEINE GUAIFENESIN-CODEINE HYDROCODONE BITARTRATE HYDROCODONE BT-HOMATROPINE MBR HYDROCODONE-ACETAMINOPHEN HYDROCODONE-CHLORPHENIRAMNE ER HYDROCODONE-HOMATROPINE MBR HYDROCODONE-IBUPROFEN HYDROMET HYDROMORPHONE HCL INFUMORPH IOPHEN-C NR LAZANDA LEVORPHANOL TARTRATE LORTAB MEPERIDINE HCL MORPHINE SULFATE NORCO NUCYNTA OPANA OPIUM TINCTURE OXAYDO OXYCODONE HCL OXYCODONE HCL-ASPIRIN OXYCODONE HCL-IBUPROFEN OXYCODONE HYDROCHLORIDE OXYCODONE-ACETAMINOPHEN OXYMORPHONE HCL PENTAZOCINE-NALOXONE HCL PERCOCET PRIMLEV PROMETHAZINE VC-CODEINE PROMETHAZINE-CODEINE PROMETHAZINE-PHENYLEPH-CODEINE ROXICODONE SUBSYS SUFENTANIL CITRATE TRAMADOL HCL TRAMADOL HCL-ACETAMINOPHEN TUSSIGON TUSSIONEX TYLENOL-CODEINE NO.3 TYLENOL-CODEINE NO.4 ULTRACET ULTRAM VICODIN VICODIN ES VICODIN HP VIRTUSSIN AC Other medications, used primarily to
    [Show full text]
  • Use of Antitussives After the Initiation of Angiotensin-Converting Enzyme Inhibitors
    저작자표시-비영리-변경금지 2.0 대한민국 이용자는 아래의 조건을 따르는 경우에 한하여 자유롭게 l 이 저작물을 복제, 배포, 전송, 전시, 공연 및 방송할 수 있습니다. 다음과 같은 조건을 따라야 합니다: 저작자표시. 귀하는 원저작자를 표시하여야 합니다. 비영리. 귀하는 이 저작물을 영리 목적으로 이용할 수 없습니다. 변경금지. 귀하는 이 저작물을 개작, 변형 또는 가공할 수 없습니다. l 귀하는, 이 저작물의 재이용이나 배포의 경우, 이 저작물에 적용된 이용허락조건 을 명확하게 나타내어야 합니다. l 저작권자로부터 별도의 허가를 받으면 이러한 조건들은 적용되지 않습니다. 저작권법에 따른 이용자의 권리는 위의 내용에 의하여 영향을 받지 않습니다. 이것은 이용허락규약(Legal Code)을 이해하기 쉽게 요약한 것입니다. Disclaimer 약학 석사학위 논문 안지오텐신 전환 효소 억제제 개시 이후 진해제의 사용 분석 Use of Antitussives After the Initiation of Angiotensin-Converting Enzyme Inhibitors 2017년 8월 서울대학교 대학원 약학과 사회약학전공 권 익 태 안지오텐신 전환 효소 억제제 개시 이후 진해제의 사용 분석 Use of Antitussives After the Initiation of Angiotensin-Converting Enzyme Inhibitors 지도교수 홍 송 희 이 논문을 권익태 석사학위논문으로 제출함 2017년 4월 서울대학교 대학원 약학과 사회약학전공 권 익 태 권익태의 석사학위논문을 인준함 2017년 6월 위 원 장 (인) 부 위 원 장 (인) 위 원 (인) Abstract Use of Antitussives After the Initiation of Angiotensin-Converting Enzyme Inhibitors Ik Tae Kwon Department of Social Pharmacy College of Pharmacy, Seoul National University Background Angiotensin-converting enzyme inhibitors (ACEI) can induce a dry cough, more frequently among Asians. If healthcare professionals fail to detect coughs induced by an ACEI, patients are at risk of getting antitussives inappropriately instead of discontinuing ACEI. The purpose of this study was to examine how the initiation of ACEI affects the likelihood of antitussive uses compared with the initiation of Angiotensin Receptor Blocker (ARB) and to determine the effect of the antitussive use on the duration and adherence of therapy in a Korean population.
    [Show full text]
  • DXM Fast Facts
    What is DXM? doses—usually at least half an 8-ounce ketamine. While under the influence of bottle—by drinking the liquid very the drug, which can last for as long as DXM (dextromethorphan) is a quickly. (Consumption of large quanti- 6 hours, DXM abusers risk injuring cough suppressant available in a ties of cough syrup induces vomiting. themselves and others because of the variety of over-the-counter cough and Thus, to achieve the desired effects, drug’s effects on visual perception and cold medications. DXM is abused abusers must drink the product quickly cognitive processes. because, when taken in doses that enough to allow the body to absorb the In addition, individuals who ingest dramatically exceed those recom- DXM before vomiting occurs.) mended by physicians and pharma- high doses of DXM risk hyperthermia cists, it produces hallucinations and The availability of powdered extrac- (exceptionally high fever), particularly if a sense of dissociation. tions of DXM has resulted in abusers they use the drug in a hot environment either inhaling the powder (snorting) or or while physically exerting themselves— What does DXM look like? repackaging it in capsules, which are such as at a rave or dance club. Other then swallowed. risks associated with DXM abuse As an over-the-counter medication, include nausea, abdominal pain, vomit- DXM is available in various forms Who abuses DXM? ing, irregular heartbeat, high blood including liquids, lozenges, tablets, pressure, headache, numbness of capsules, and gel caps. In addition, DXM It is difficult to gauge the extent of fingers and toes, loss of consciousness, powder—prepared by extracting the drug DXM abuse in the United States seizures, brain damage, and death.
    [Show full text]
  • Helicidine, Un Extrait Doses May Be Given
    1562 Cough Suppressants Expectorants Mucolytics and Nasal Decongestants UK preparations suggest that these doses be given up to a maxi- ◊ References. Ipecacuanha mum of 4 times daily, although in other countries higher total 1. Pons F, et al. L’effect bronchorelaxant de l’helicidine, un extrait doses may be given. d’Helix pomatia, fait intervenir une liberation de prostaglandine Hlavěnkový kořen; Ipecac; Ipecacuana; Ipécacuanha, racine d’; E2. Pathol Biol (Paris) 1999; 47: 73–80. Respiratory disorders. An FDA review of preparations avail- Ipecacuanha Root; Ipecacuanhae radix; Ipekakuána-gyökér; able over-the-counter concluded that guaifenesin was an effec- Preparations Ipekakuananjuuri (ipecacuanha root); Ipekakuanarot (ipecacuan- tive expectorant.1 The use of expectorants for productive cough Proprietary Preparations (details are given in Part 3) ha root); Ipekakuanu˛ šaknys; Korzeń ipekakuany; Raíz de ipecac- 2 uana. is discussed on p.1547. A small study found that guaifenesin Multi-ingredient: Ger.: Original Schneckensirup†. also appeared to reduce cough reflex sensitivity in patients with Ипекакуана upper respiratory-tract infections, which produce a transient in- CAS — 8012-96-2. crease in sensitivity, although it had no effect on cough reflex in ATC — R05CA04; V03AB01. Indanazoline Hydrochloride (rINNM) ⊗ healthy subjects. The mechanism for this effect was unclear. ATC Vet — QR05CA04; QV03AB01. Guaifenesin has been given to patients with altered nasal muco- Hidrocloruro de indanazolina; Indanazolin Hidroklorür; Indana- 3 Pharmacopoeias. In Eur. (see p.vii), Int., Jpn, and US. ciliary clearance associated with HIV infection. zoline, Chlorhydrate d’; Indanazolini Hydrochloridum. 1. Thomas J. Guaiphenesin—an old drug now found to be effective. Eur., Jpn, and US also include a monograph for Prepared Ipecac- Aust J Pharm 1990; 71: 101–3.
    [Show full text]
  • Estonian Statistics on Medicines 2016 1/41
    Estonian Statistics on Medicines 2016 ATC code ATC group / Active substance (rout of admin.) Quantity sold Unit DDD Unit DDD/1000/ day A ALIMENTARY TRACT AND METABOLISM 167,8985 A01 STOMATOLOGICAL PREPARATIONS 0,0738 A01A STOMATOLOGICAL PREPARATIONS 0,0738 A01AB Antiinfectives and antiseptics for local oral treatment 0,0738 A01AB09 Miconazole (O) 7088 g 0,2 g 0,0738 A01AB12 Hexetidine (O) 1951200 ml A01AB81 Neomycin+ Benzocaine (dental) 30200 pieces A01AB82 Demeclocycline+ Triamcinolone (dental) 680 g A01AC Corticosteroids for local oral treatment A01AC81 Dexamethasone+ Thymol (dental) 3094 ml A01AD Other agents for local oral treatment A01AD80 Lidocaine+ Cetylpyridinium chloride (gingival) 227150 g A01AD81 Lidocaine+ Cetrimide (O) 30900 g A01AD82 Choline salicylate (O) 864720 pieces A01AD83 Lidocaine+ Chamomille extract (O) 370080 g A01AD90 Lidocaine+ Paraformaldehyde (dental) 405 g A02 DRUGS FOR ACID RELATED DISORDERS 47,1312 A02A ANTACIDS 1,0133 Combinations and complexes of aluminium, calcium and A02AD 1,0133 magnesium compounds A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 811120 pieces 10 pieces 0,1689 A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 3101974 ml 50 ml 0,1292 A02AD83 Calcium carbonate+ Magnesium carbonate (O) 3434232 pieces 10 pieces 0,7152 DRUGS FOR PEPTIC ULCER AND GASTRO- A02B 46,1179 OESOPHAGEAL REFLUX DISEASE (GORD) A02BA H2-receptor antagonists 2,3855 A02BA02 Ranitidine (O) 340327,5 g 0,3 g 2,3624 A02BA02 Ranitidine (P) 3318,25 g 0,3 g 0,0230 A02BC Proton pump inhibitors 43,7324 A02BC01 Omeprazole
    [Show full text]
  • How to Anesthetize Donkeys for Surgical Procedures in the Field
    DRUGS AND ANESTHESIA How to Anesthetize Donkeys for Surgical Procedures in the Field Lori A. Bidwell, DVM, Diplomate ACVA Author’s address: Ross University School of Veterinary Medicine, PO Box 334, St. Kitts, West Indies; e-mail: [email protected]. © 2010 AAEP. 1. Introduction ing a local block where a catheter will be placed and Donkeys are an important part of the work force in making a small skin incision with a surgical blade much of the world. Practitioners working with before placing an intravenous catheter is recom- donkeys in the United States and those participat- mended. Intubation is more difficult because of ing in equitarian initiatives abroad should under- caudal angulation of the larynx, a pharyngeal diver- stand the difference between donkeys and horses in ticulum, excess pharyngeal mucosa, and long paired relation to anesthesia. Although it is tempting to laryngeal saccules. Additionally, nasal intubation 1 treat a donkey like a horse, there are important is complicated by narrow nasal passages. Drug differences in relation to handling and drug doses. metabolism is elevated in donkeys compared with Additionally, it is important to understand alterna- horses, resulting in the use of higher doses and more 2–6 tive anesthetic protocols because a practitioner may frequent dosing intervals. The only known ex- be limited to minimal or alternative drugs when ception to this is the administration of guaifenesin, working in a developing country. which seems to require lower dosing because respi- ratory arrest is easy to achieve when using doses 7 2. Behavior and Physiology appropriate for a horse. A tame donkey can be easy to handle but a feral or minimally handled donkey can be frustrating.
    [Show full text]
  • National OTC Medicines List-2018
    National OTC Medicines List – First Edition 2018 NATIONAL OTC MEDICINES LIST First Edition 2018 Foreword According to the French National Agency for Medicines and Health Products Safety (ANSM), Over‐the‐ counter (OTC) drugs are medicines that are accessible to patients in pharmacies, based on criteria set to safeguard patients’ safety. FDA’s Center for Drug Evaluation and Research (CDER) regulates over‐the‐counter (OTC) which are drugs that have been found to be safe and appropriate for use without the supervision of a health care professional such as a physician, and they can be purchased by consumers without a prescription. Due to their therapeutic class, these medicines could be dispensed without physician’s intervention for diagnostic, treatment initiation or maintenance purposes. According to Arcle 43 of the Law No.367 issued in 1994 related to the pharmacy practice, and the amendment of Arcles 46 and 47 by Law No.91 issued in 2010, pharmacists do not have the right to dispense any medicine that is not requested through a unified prescription, unless the medicine is mentioned in a list which is established by the Orders of Pharmacists and Physicians In this regards, the Ministry of Public Health (MoPH) developed the National OTC list, presented it in a scientific, objective, reliable and accessible listingand issued by a Ministerial decision. At this stage, no “convenience size packaging” nor “restriction to a maximum dose” or a “maximum dose per day” or “length of treatment” were considered for some molecules to allow them to be classified as OTC. The list covers medicines that are intended to relief patients from minor to moderate symptoms for a determined period, and procured with the pharmacist’s assistance without the physician’s intervention.
    [Show full text]
  • Guaifenesin, Dextromethorphan, and Phenylephrine
    PATIENT & CAREGIVER EDUCATION Guaifenesin, Dextromethorphan, and Phenylephrine This information from Lexicomp® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider. Brand Names: US Aquanaz [OTC]; Deconex DMX [OTC]; Duravent DM [OTC] [DSC]; Gcon DMX [OTC]; GoodSense Mucus Relief Child [OTC]; GoodSense Mucus/Congest/Cough [OTC]; GoodSense Tussin CF [OTC]; Mucinex Childrens Freefrom [OTC]; Mucinex Cold Childrens [OTC]; Mucinex Congest & Cough Child [OTC] [DSC]; Mucinex Cough & Congest Child [OTC]; Mucinex Fast-Max Congest Cough [OTC]; Mucinex Freefrom Sev Cngst/Cgh [OTC]; Mucinex Junior Cough/Congest [OTC]; NeoTuss- D [OTC] [DSC]; Nivanex DMX [OTC]; Relhist DMX [OTC] [DSC]; Robafen CF Multi- Symptom Cold [OTC]; Robitussin Child Cough/Cold CF [OTC]; Robitussin Multi- Symptom Max [OTC] [DSC]; Robitussin Peak Cold Multi-Sym [OTC]; Robitussin To Go Cough/Cold CF [OTC] [DSC] What is this drug used for? It is used to treat nose stuffiness. It is used to relieve coughing. It is used to thin mucus so it can be taken from the body by coughing. Guaifenesin, Dextromethorphan, and Phenylephrine 1/6 What do I need to tell the doctor BEFORE my child takes this drug? If your child is allergic to this drug; any part of this drug; or any other drugs, foods, or substances. Tell the doctor about the allergy and what signs your child had. If your child has any of these health problems: Cough with a lot of mucus, a long-term cough caused by smoking or being around smoke, or lung problems like asthma.
    [Show full text]